FNYS
ASPX

First New York Securities’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

First New York Securities’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-31
Closed -$3.11K – 611
2015
Q1 		$3.11K Buy
+31
New +$2.06K ﹤0.01% 329

First New York Securities's ASPX Position: Q2 2015 in Review

First New York Securities sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 31 shares — an estimated $3.11K sold.

First New York Securities first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $3.11K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • First New York Securities reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • First New York Securities sold 31 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $3.11K.
  • First New York Securities first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • First New York Securities's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.11K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on First New York Securities's 13F filing for Q2 2015, filed 30 Jul 2015.